Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Maculopathy”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Looking for participantsNCT05003986
What this trial is testing

Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases

Who this might be right for
Focal Segmental GlomerulosclerosisMinimal Change DiseaseImmunoglobulin A Nephropathy+2 more
Travere Therapeutics, Inc. 67
Not applicableUnknownNCT04739137
What this trial is testing

Smart-TV Application for the Self Examination of the Distance Visual Acuity in Macular Edema Patients

Who this might be right for
Low VisionMacular EdemaRefractive Errors
Democritus University of Thrace 300
Post-approval studies (Phase 4)UnknownNCT01213667
What this trial is testing

Genetics in Non-response to Anti-VEGF Treatment in Exudative AMD

Who this might be right for
Macular Degeneration
University of Cologne 110
Not applicableStudy completedNCT03803631
What this trial is testing

CNV in AMD Analyzed by OCT Angiography Under IntravitreaL Eylea (COCTAEyl)

Who this might be right for
AMDExudative Macular Degeneration
Centre Hospitalier Intercommunal Creteil 49
Not applicableEnded earlyNCT01717937
What this trial is testing

Comparison of Phase-variance Optical Coherence Tomography and Fluorescein Angiography in Retinovascular Imaging

Who this might be right for
Age-related Macular DegenerationDiabetic RetinopathyHypertensive Retinopathy+2 more
University of California, San Francisco 10
Not applicableStudy completedNCT03919019
What this trial is testing

Morpho-functional Changes After Oral Supplementation of Antioxidants and Anti-inflammatory Treatment in Age-Related Macular Degeneration.

Who this might be right for
Dry AMD
Fondazione G.B. Bietti, IRCCS 30
Not applicableLooking for participantsNCT06445322
What this trial is testing

Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials (STARPATH)

Who this might be right for
Stargardt DiseaseStargardt Disease 1Cone Rod Dystrophy+1 more
Ascidian Therapeutics, Inc 50
Not applicableUnknownNCT00380172
What this trial is testing

Long-Term Efficacy in AMD of Rheopheresis in North America

Who this might be right for
Macular Degeneration
OccuLogix 120
Testing effectiveness (Phase 2)Study completedNCT00470977
What this trial is testing

Treatment of Exudative and Vasogenic Chorioretinal Diseases Including Variants of AMD and Other CNV Related Maculopathy

Who this might be right for
Coats' DiseaseIdiopathic Retinal TelangiectasiaRetinal Angiomatous Proliferation+7 more
Manhattan Eye, Ear & Throat Hospital 18
Not applicableStudy completedNCT02090751
What this trial is testing

Development of a Device to Measure Dark Adaptation

Who this might be right for
Macular DegenerationAge-Related Macular Degeneration
University of Manchester 40
Testing effectiveness (Phase 2)Ended earlyNCT01577381
What this trial is testing

Efficacy, Safety And Tolerability Study Of RN6G In Subjects With Geographic Atrophy Secondary to Age-related Macular Degeneration

Who this might be right for
Age-Related Maculopathy
Pfizer 10
Not applicableStudy completedNCT02528058
What this trial is testing

Ultrastructure Analysis of Excised Internal Limiting Membrane in Eyes of Highly Myopia With Myopic Traction Maculopathy

Who this might be right for
Myopic Traction Maculopathy
Kyorin University 7
Early research (Phase 1)UnknownNCT00767949
What this trial is testing

Safety Study of iSONEP (Sonepcizumab/LT1009) to Treat Neovascular Age-related Macular Degeneration

Who this might be right for
Neovascular Age Related Macular Degeneration
Lpath, Inc. 15
Large-scale testing (Phase 3)Ended earlyNCT00642226
What this trial is testing

Combined Vitrectomy and Triamcinolone in Macular Edema Secondary to Branch Retinal Vein Occlusion (BRVO)

Who this might be right for
Branch Retinal Vein OcclusionMacular Edema
Helse Stavanger HF 34
Testing effectiveness (Phase 2)Study completedNCT01284478
What this trial is testing

Ozurdex for Combined Pseudophakic Cystoid Macular Edema and Diabetic Macular Edema After Cataract Surgery

Who this might be right for
Pseudophakic Cystoid Macular Edema,Diabetic Macular Edema
Northern California Retina Vitreous Associates 6
Large-scale testing (Phase 3)Study completedNCT00242580
What this trial is testing

A Safety and Efficacy Study Comparing the Combination Treatments of Verteporfin Therapy Plus One of Two Different Doses of Intravitreal Triamcinolone Acetonide and the Verteporfin Therapy Plus Intravitreal Pegaptanib

Who this might be right for
Macular DegenerationChoroidal Neovascularization
Novartis Pharmaceuticals 111
Testing effectiveness (Phase 2)Ended earlyNCT01603043
What this trial is testing

A Multicenter, Proof-Of-Concept Study Of Intravitreal AL-78898A In Patients With Geographic Atrophy (GA) Associated With Age-Related Macular Degeneration (AMD)

Who this might be right for
Geographic Atrophy
Alcon Research 10
Not applicableStudy completedNCT01670643
What this trial is testing

Reading Performance With a Video Magnifier

Who this might be right for
Macular Degeneration
Mary Lou Jackson 120
Not applicableLooking for participantsNCT07019896
What this trial is testing

Minimal Vitrectomy Surgery for Epiretinal Membrane

Who this might be right for
Epiretinal MembraneMacular Edema (ME)Nuclear Cataract
Peking Union Medical College Hospital 140
Testing effectiveness (Phase 2)Study completedNCT05456828
What this trial is testing

ASKG712 in Patients With Neovascular Age-Related Macular Degeneration

Who this might be right for
Neovascular Age-related Macular Degeneration
Visara, Inc. 56
Next Page